Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. PT (1:30 p.m. ET).
波士頓，2025年1月9日 /PRNewswire/ -- Ginkgo Bioworks（紐交所：DNA），正在建立電芯編程和生物安全的領先平台，今天宣佈聯合創始人兼首席執行官傑森·凱利計劃於2025年1月16日（星期四）上午10:30（太平洋時間）在第43屆摩根大通醫療會議上發表演講。
Further details, a webcast link, and a replay of the presentation will be posted on the company's investor relations website at
更多詳細信息、網絡研討會鏈接和演示回放將發佈在公司的投資者關係網站上。
About Ginkgo Bioworks
關於Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
Ginkgo Bioworks是領先的細胞編程水平平台，提供靈活的、端到端的服務，以解決來自食品和農業、製藥到工業和特種化學品等各類市場的組織面臨的挑戰。Ginkgo生物安全正致力於建設和部署全球領導者所需的下一代基礎設施和技術，以預測、檢測和應對各種生物威脅。有關更多信息，請訪問ginkgobioworks.com和ginkgobiosecurity.com，閱讀我們的博客，或者關注我們的社交媒體渠道，如X (@Ginkgo和@Ginkgo_Biosec)、Instagram (@GinkgoBioworks)、Threads (@GinkgoBioworks)或LinkedIn。
Ginkgo Bioworks Contacts:
Ginkgo Bioworks 聯繫方式：
INVESTOR CONTACT:
[email protected]
投資者聯繫方式：
[email protected]
MEDIA CONTACT:
[email protected]
媒體聯繫方式：
[email protected]
SOURCE Ginkgo Bioworks
來源 Ginkgo Bioworks
